Financial Advisory Shortlist 2021
View the financial advisory shortlist for Mergermarket's European M&A Awards 2021.
View the financial advisory shortlist for Mergermarket's European M&A Awards 2021.
View the legal advisory shortlist for Mergermarket's European M&A Awards 2021.
Tell us the story of your year in just 300 words.
The volume of announced deals involving UK targets in the first two quarters of the year fell 68.6% compared to the same period last year, leading to the quietest start to a calendar year for dealmaking since 2009.
Mergermarket data shows that the German-speaking region ended the first half of 2020 in terms of M&A better off than the rest of the continent.
Regional dealmakers remain cautious about the prospects of an M&A recovery in Central and Eastern Europe (CEE). Nonetheless, in spite of fears surrounding a second wave of the pandemic, activity is reigniting in selected sectors, albeit under "new normal" conditions.
At the half-year stage, US dealflow was down sharply whilst China was least impacted. Megadeals declined although mid-market showed resiliency. Meanwhile, private equity's global M&A market share reached record level.
Private equity firms have become increasingly interested in professional sports.
Watch Mergermarket’s Virtual Event on the M&A market outlook in Benelux in partnership with Datasite here.
Watch Mergermarket’s Virtual Event on the M&A market outlook in the CEE region here.
European M&A looks set to remain at historically low levels through 2020 with a recovery unlikely until mid-2021, as the world continues to grapple with the coronavirus pandemic and its economic consequences.
Watch Mergermarket’s Virtual Event on the ItalianM&A outlook and the impact of Covid-19.
Watch Mergermarket’s Virtual Event on the UK M&A market outlook and the impact of Covid-19 here.
Survey of 60 global dealmakers shows many are reconsidering M&A as they wait out the ongoing pandemic amid rising fears of a global recession.
Watch Mergermarket’s Virtual Event on the Nordic market outlook and the impact of Covid-19 here.
No sector is closer than healthcare to the front-lines of the covid-19 pandemic.
Not only is the pandemic shaking up businesses in the sector, it is creating opportunities for dealmaking. Indeed, Thermo Fisher’s [NYSE:TMO] proposed takeover of diagnostics firm Qiagen [NYSE:QGEN] shows how the crisis can make the case for M&A.
In this week’s podcast, Mergermarket healthcare editor Mintoi Chessa-Florea, Mergermarket healthcare reporter Davide Salvi and Dealreporter analyst William Cain join us to discuss the sector. At issue are: pre-covid-19 M&A trends, the effect of the pandemic on business cases, the effect of the pandemic on M&A and ECM, and the outlook for Qiagen/Thermo Fisher.
An error occurred trying to play the stream. Please reload the page and try again.
Close